|
KMID : 1146320140020020130
|
|
Journal of Health Technology Assessment
2014 Volume.2 No. 2 p.130 ~ p.136
|
|
|
The Budgetary Impact of Smoking Cessation Treatment in Korea
|
|
Ko Su-Kyoung
Lee Ju-Yeon
Park Da-Jin
|
|
|
Abstract
|
|
|
Objectives: To estimate the budgetary impact of smoking cessation treatment in Korea in the first 5 years after policy change related to reimbursement of smoking cessation treatment from the healthcare perspective.
Methods: In the economic impact model, target populations were adult smokers who were over 20-year old, decided to quit smoking, and took medication for smoking cessation through hospital or clinic visits. Assumed baseline rate of smoking, decision to quit, hospital/ clinic visit, and prescription of smoking cessation treatment was 42.1% (male) and 6.2% (female), 55.3%, 5.4%, and 13% respectively. Annual increase rates of smoking, trial to quit smoking, hospital/clinic visits, and prescription of smoking cessation treatment were estimated as -1.8%, 5%, 5%, and 20% respectively during 5 years. Smoking cessation treatments based on three alternatives were estimated: nicotine replacement therapy, bupropion, and varenicline. All drug costs are calculated based on 12-week treatment. Sensitivity analysis was performed to evaluate the impact of varying the smoking rate.
Results: Model estimates suggest that the budgetary impact of smoking cessation treatments would be 40 billion KRW in 2014. and in the fifth year after policy change, total smoking cessation programs would be 109 billion KRW in 2019.
Conclusion: Reimbursement of smoking cessation treatment could result in additional national budget of 70 billion KRW annually. But we can expect a reduction in the number of smokers would offset this cost by decreasing the burden of smoking.
|
|
|
KEYWORD
|
|
|
Budget impact analysis, Smoking cessation treatment
|
|
|
FullTexts / Linksout information
|
|
|
|
|
|
Listed journal information
|
|
|
|
|